Literature DB >> 7054121

Transfer of resistance with syphilitic immune cells: lack of correlation with mitogenic activity.

R F Schell, J L LeFrock, J K Chan.   

Abstract

Hamsters infected intradermally with Treponema pallidum Bosnia A develop extensive chronic skin lesions, usually accompanied by metastatic lesions involving the paws, lips, and anal region and by lymph nodes teeming with treponemes. Throughout the course of syphilitic infection, cells from the inguinal lymph nodes responded poorly to stimulation with suboptimal, optimal, or supraoptimal concentrations of concanavalin A, phytohemagglutinin P, or lipopolysaccharide. The response of syphilitic spleen cells was variable. Depression of lymphocyte reactivity to mitogens preceded clinical signs of infection and correlated well with the chronicity of syphilitic infection. When syphilitic hamsters were treated with a curative dose of penicillin, their mitogenic responses returned to normal or were slightly elevated. No correlation existed between mitogenic activity and the ability of lymphoid cells to induce an effective immune response when transferred to normal recipients. No significant differences in protection were detected among recipients of immune cells with or without activity to mitogens. These results demonstrate that lymphocyte transformation by mitogens in vitro is not a measure of effective treponemicidal activity and so may not be a valid indicator of the protective immune status of syphilitic animals.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7054121      PMCID: PMC351014          DOI: 10.1128/iai.35.1.187-192.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  The role of temperature in experimental treponemal infection.

Authors:  D H HOLLANDER; T B TURNER
Journal:  Am J Syph Gonorrhea Vener Dis       Date:  1954-11

2.  Protein A : a B cell mitogen for hamster splenic lymphoid cells.

Authors:  A Duthu; H Haddada; N Le Goffic; C de Vaux-Saint-Cyr
Journal:  Dev Comp Immunol       Date:  1980       Impact factor: 3.636

3.  The role of cell-mediated immune mechanisms in syphilis in Ethiopia.

Authors:  P S Friedmann; J L Turk
Journal:  Clin Exp Immunol       Date:  1978-01       Impact factor: 4.330

4.  LSH hamster model of syphilitic infection.

Authors:  R F Schell; J L LeFrock; J K Chan; O Bagasra
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

5.  Surface-associated host proteins on virulent Treponema pallidum.

Authors:  J F Alderete; J B Baseman
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

6.  Reactivity of lymphocytes from patients with syphilis towards T. pallidum antigen in the leucocyte migration and lymphocyte transformation tests.

Authors:  E From; K Thestrup-Pedersen; H Thulin
Journal:  Br J Vener Dis       Date:  1976-08

7.  Depression of lymphocyte response to concanavalin A in rabbits infected with Treponema pallidum (Nichols strain).

Authors:  C S Pavia; J D Folds; J B Baseman
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

8.  In vitro cell response of Treponema pallidum-infected rabbits. I. Lymphocyte transformation.

Authors:  V Wicher; K Wicher
Journal:  Clin Exp Immunol       Date:  1977-09       Impact factor: 4.330

9.  Alterations in the distribution and proliferative responses of rhesus monkey peripheral blood and spleen cells during malaria (Plasmodium knowlesi) infection.

Authors:  D W Taylor; S R Crum; K J Kramer; W A Siddiqui
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

10.  Molecular characterization of receptor binding proteins and immunogens of virulent Treponema pallidum.

Authors:  J B Baseman; E C Hayes
Journal:  J Exp Med       Date:  1980-03-01       Impact factor: 14.307

View more
  1 in total

1.  Enhanced primary resistance to Treponema pallidum infection and increased susceptibility to toxoplasmosis in T-cell-depleted guinea pigs.

Authors:  C S Pavia
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.